Stay updated on MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Sign up to get notified when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.

Latest updates to the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe Record History page text changes include the link text capitalization for contacting information and the addition of a new revision label (Revision: v3.7.0), while the previous label (Revision: v3.6.6) and the old link text were removed.SummaryDifference0.2%

- Check47 days agoChange DetectedThe study record's revision history was updated to include a new revision (v3.6.6) and remove the previous one (v3.6.5), reflecting an update to the page's history log.SummaryDifference0.1%

- Check68 days agoChange DetectedThe study record history shows a new revision v3.6.5 added and the previous revision v3.6.4 removed, updating the revision history for this record.SummaryDifference0.1%

- Check83 days agoChange DetectedThe record history now shows a new Revision: v3.6.4, replacing v3.6.3, indicating a minor platform update to the study record page.SummaryDifference0.1%

- Check105 days agoChange DetectedThe history now shows a new Revision: v3.6.3 entry and the previous Revision: v3.6.2 entry was removed. This reflects a minor software version update to the page.SummaryDifference0.1%

Stay in the know with updates to MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.